Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/26/16 → 10/25/20 |
Funding
- Astellas Pharma Global Development Incorporated: $301,917.19
Protocol#IDTX-MA-3004 Astrafraf XL to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation
- Kayler, Liise (PI)
- Patel, Sunil (PI)
Project: Research